跳至主要内容
临床试验/NCT04963257
NCT04963257招募中4 期

A Randomized Controlled Trial of Sertraline Combined With Fluvoxamine in the Treatment of Refractory Obsessive-compulsive Disorder

Second Affiliated Hospital, School of Medicine, Zhejiang University1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2020年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
400
试验地点
1
主要终点
Y-BOCS score

研究概览

简要总结

To verify that sertraline combined with fluvoxamine is superior to sertraline combined with aripiprazole

详细描述

To verify that sertraline combined with fluvoxamine is superior to sertraline combined with aripiprazole, and to observe the indicators of improving patients' cognitive function and adverse drug reactions, so as to provide evidence-based evidence for supplementing the treatment guidelines for obsessive-compulsive disorder

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
12 Years 至 45 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • The Diagnostic criteria of OCD in the Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-V), as well as the definition of refractory OCD, are as follows: failure to respond to oral treatment with at least two effective doses of antidepressants, including: Fluoxetine (≥20mg/ d), fluvoxamine (≥200mg/d), sertraline (≥150mg/d), and paroxetine (≥ 40mg/d) were all treated for at least 12 weeks. The Yale-Brown compulsive scale (Y-BOCS) score decreased by < 35%.
  • The total score of Yale- Brown compulsion scale (Y-BOCS) ≥16 points. (3)age 12 ~ 45 years.

排除标准

  • Exclusion of severe organic brain disease;
  • Severe physical illness;
  • Other mental disorders such as tics, disruptive disorders, eating disorders and autism spectrum disorders;
  • Pediatric streptococcal infection causedby autoimmune neuropsychiatric disease (PANDAS);
  • Alcohol and drug dependence; Angle-closure glaucoma;
  • Suicidal tendencies;
  • Previous history of drug allergies related to research;
  • Pregnant and lactating women.

研究组 & 干预措施

sertraline combined with fluvoxamine

Experimental

Sertraline combined with fluvoxamine treatment group: Gradually add the drug to the treatment dose, and monitor the symptom change, scale score, blood drug concentration and other indicators

干预措施: sertraline fluvoxamine (Drug)

sertraline combined with aripiprazole

Active Comparator

sertraline combined with aripiprazole treatment group:Gradually add the drug to the treatment dose, and monitor the symptom change, scale score, blood drug concentration and other indicators

干预措施: sertraline (Drug)

结局指标

主要结局

Y-BOCS score

时间窗: 12 weeks

Treatment effectiveness was defined as a reduction of ≥35% in Y-BOCS score compared to baseline(12 weeks). Treatment recovery: Y-BOCS score below 8 (12 weeks)

Ratio of Y-BOCS score reduction from baseline

时间窗: 12 weeks

Treatment effectiveness was defined as a reduction of ≥35% in Y-BOCS score compared to baseline(12 weeks).

次要结局

未报告次要终点

研究者

发起方
Second Affiliated Hospital, School of Medicine, Zhejiang University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验